This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Freireich EJ (1997) Regulatory issues. In Cancer: Principles and Practice of Oncology, edn 5, 2966–2972 (Eds DeVita Jr VT et al.) Philadelphia: Lippincott–Raven
Hutt PB (1993) The regulation of pharmaceutical products in the USA. In Pharmaceutical Medicine, edn 2, 211 (Eds Burley DM et al.). Boston: Edward Arnold
Pharmaceutical research and manufacturers of America (online March 2005) Pharmaceutical industry profile 2005. From laboratory to patient: pathways to biopharmaceutical innovation. [http://www.phrma.org/publications/publications/2005-03-17.1143.pdf] (accessed 24 November 2005)
Freireich EJ and Bodey GP (1984) Evaluation of new agents: planning, execution and evaluation of clinical studies. In Clinical Chemotherapy, 115 (Eds Kuemmerle HP et al.) New York: Thieme-Stratton
Joravsky D (2005) Lysenkoism. In New Dictionary of the History of Ideas, 1321–1323 (Ed. Horowitz M) Detroit: Charles Scribner's Sons
National Institutes of Health Office for Protection from Research Risks (1991) OPRR Reports: protection of human subjects. (Title 45, Code of Federal Regulations, part 46). Bethesda: OPRR
Lasagna I and Bodey GP (1996) The impact of regulations, tradition and experimental design on clinical cancer trials: report and recommendations resulting from Washington cancer trials conference. Am J Clin Oncol 19: 325
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Freireich, E. The investigational new drug application—who benefits?. Nat Rev Clin Oncol 3, 62–63 (2006). https://doi.org/10.1038/ncponc0429
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncponc0429